PPARA and metabolic dysfunction-associated steatotic liver disease: The CPT-1 can mediate the transport of long-chain fatty acids into mitochondria, where they are catalyzed by MCAD for β-oxidation [10]. Conceivably, activation of the PPARα-related signaling can promote fatty acid β-oxidation and degradation, alleviating hyperlipidemia and NAFLD.